Citation Impact

Citing Papers

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation
2002 StandoutNobel
Fetal Hemoglobin, Sickling, and Sickle Cell Disease
1990
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Establishing, maintaining and modifying DNA methylation patterns in plants and animals
2010 Standout
Sickle cell disease: old discoveries, new concepts, and future promise
2007
Genetic analysis of β-thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotype
1997
Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues
2009
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Pulmonary Arterial Hypertension in Previously Splenectomized Patients with β-Thalassemic Disorders
2003
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Intergenic Transcription, Cell-Cycle and the Developmentally Regulated Epigenetic Profile of the Human Beta-Globin Locus
2007
The β-Thalassemias
1999 Standout
Replication and transcription: Shaping the landscape of the genome
2005
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Identification and characterization of a spinal muscular atrophy-determining gene
1995 Standout
Sickle Cell Anaemia
2002
Genetic Analysis of Innate Immunity
2006 StandoutNobel
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
2009 StandoutNature
Predicting clinical severity in sickle cell anaemia
2005
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
1 The population genetics of the haemoglobinopathies
1998
Retroelements and their impact on genome evolution and functioning
2009
6 β-Thalassaemia
1993
The muscular dystrophies
2002 Standout
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
2018
Clinical classification of pulmonary hypertension
2004 Standout
Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias
2001
Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era
2015 Standout
Sickle cell disease in India
2014
The effect of hypoxia in development
2007
Molecular Basis of β-Thalassemia in the Maldives
1998
Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia
1995
Anemia and the liver
2002
Alpha thalassemia and stroke risk in sickle cell anemia
1994
Circadian control of the immune system
2013 Standout
Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in β thalassaemia
1998
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
2009 Standout
8 The population genetics of the haemoglobinopathies
1993
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
2004 StandoutNobel
Gene Defects in β‐Thalassemia and Their Prenatal Diagnosis
1990
5 α-Thalassaemia
1993
Sickle-cell disease
2010 Standout
The cancer stem cell: premises, promises and challenges
2011 Standout
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Homology requirements for unequal crossing over in humans.
1991 StandoutNobel
Modulation of the Phenotypic Diversity of Sickle Cell Anemia
1996
Global epidemiology of haemoglobin disorders and derived service indicators
2008 Standout
7 Increased HbF in adult life
1993
World distribution of factor V Leiden
1995 Standout
A Multiprotein Complex That Interacts with RNA Polymerase II Elongator
2001 StandoutNobel
Hypercoagulability in sickle cell disease: a curious paradox
2003
Interpreting neural networks for biological sequences by learning stochastic masks
2022 StandoutNobel
RNA-directed DNA methylation mediated by DRD1 and Pol IVb: A versatile pathway for transcriptional gene silencing in plants
2007
Sickle cell disease in Africa: burden and research priorities
2007
Selective Autophagy Regulates Insertional Mutagenesis by the Ty1 Retrotransposon in Saccharomyces cerevisiae
2011 StandoutNobel
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Evolution and Functions of Long Noncoding RNAs
2009 Standout
Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles
1998
Two different forms of homozygous sickle cell disease occur in Saudi Arabia
1991
Why are some genetic diseases common?
1993
A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome
2001 StandoutNobel
CTCF: Master Weaver of the Genome
2009 Standout
Intergenic Transcription and Developmental Remodeling of Chromatin Subdomains in the Human β-globin Locus
2000
Regulation of the mammalian alcohol dehydrogenase genes
2000
8 Prenatal diagnosis and screening of the haemoglobinopathies
1998
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Conserved CTCF Insulator Elements Flank the Mouse and Human β-Globin Loci
2002
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
2016 StandoutNobel
Hemoglobin comparisons between African American and European American males with hemoglobin values in the normal range
1992
Racial variability in the UDP-glucuronosyltransferase 1 ( UGT1A1 ) promoter: A balanced polymorphism for regulation of bilirubin metabolism?
1998 Standout
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
1998 Standout
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease
2017
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease
2016
Guidelines for the Primary Prevention of Stroke
2014 Standout
Molecular characterization of beta-thalassemia intermedia in patients of Italian descent and identification of three novel beta-thalassemia mutations
1991
Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?
1998
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Confirmation of an Association Between the TNF(−308) Promoter Polymorphism and Stroke Risk in Children With Sickle Cell Anemia
2007
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
A Common Human β Globin Splicing Mutation Modeled in Mice
1998 StandoutNobel
Long Noncoding RNAs: Past, Present, and Future
2013 Standout
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
2013
Chromatin modification by DNA tracking
1999
Lethal thalassemia after insertional disruption of the mouse major adult beta-globin gene.
1993 StandoutNobel
FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
2007 Standout
A mouse model for beta 0-thalassemia.
1995 StandoutNobel
Glucose-6-phosphate dehydrogenase deficiency
2008 Standout
Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive Hypertension
1995 StandoutScienceNobel
Molecular basis and prenatal diagnosis of beta-thalassemia
1988
Deletion and Replacement of the Mouse Adult β-Globin Genes by a “Plug and Socket” Repeated Targeting Strategy
1994 StandoutNobel
Hydrops Fetalis Caused by α-Thalassemia: An Emerging Health Care Problem
1998
Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome.
1993
Deletion and replacement of the mouse adult beta-globin genes by a "plug and socket" repeated targeting strategy.
1994 StandoutNobel

Works of F. Kutlar being referenced

Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
2011
Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States
1988
Hydrops fetalis due to Homozygosity for α-Thalassemia-1, -(α)-20.5 kb: The First Observation in a Turkish Family
1989
Certain Mutations Observed in the 5´ Sequences of the <sup>G</sup>γ- and <sup>A</sup>γ-Globin Genes of β<sup>s</sup> Chromosomes Are Specific for Chromosomes with Major Haplotypes
1991
A Search for Anomalies in the ζ,α,β, and γ Globin Gene Arrangements in Normal Black, Italian, Turkish, and Spanish Newborns
1989
One haplotype is associated with the Swiss type of hereditary persistence of fetal hemoglobin in the Yugoslavian population
1987
A Long Terminal Repeat of the Human Endogenous Retrovirus ERV-9 Is Located in the 5′ Boundary Area of the Human β-Globin Locus Control Region
1998
The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, βS‐globin gene haplotype, co‐inherited α‐thalassemia trait and Hb F on steady‐state serum bilirubin levels in sickle cell anemia
2005
β-Thalassemia in Bulgaria
1990
Molecular characterization of β‐globin gene mutations in Malay patients with Hb E‐β‐thalassaemia and thalassaemia major
1989
Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients
1993
Molecular characterization of Hb S(C) β‐thalassemia in American blacks
1991
The levels of ?, ?, and ? chains in patients with Hb H disease
1989
An Indonesian Family with the Southeast Asian Type of α-Thalassemia-1 and a γ-Globin Gene Triplication
1987
β-Thalassemia, HB S-β-Thalassemia and Sickle Cell Anemia Among Tunisians
1991
THE METHYLENE TETRAHYDROFOLATE REDUCTASE (C677T) MUTATION AS A POTENTIAL RISK FACTOR FOR AVASCULAR NECROSIS IN SICKLE CELL DISEASE
2001
Fetal hemoglobin in normal adults and ?-thalassemia heterozygotes
1990
β-Thalassehia Mutations in the Portuguese; High Frequencies of Two Alleles in Restricted Populations
1993
The Types of Hemoglobins and Globin Chains in Hydrops Fetalis
1989
Normal Fetal Hemoglobin Levels in the Sudden Infant Death Syndrome
1989
Hemoglobinopathies Among the Gond Tribal Groups of Central India; Interaction of α- and β-Thalassemia with β Chain Variants
1991
Frequency of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients
2001
A Mild Thalassemia Major Resulting from a Compound Heterozygosity for the IVS-11-1 (G→A) Mutation and the Rare T→C Mutation at the Polyadenylation Site
1991
HB Monroe or α2β230(B12)ARG→THR, a Variant Associated with β-Thalassemia due to a G→C Substitution Adjacent to the Donor Splice Site of the First Intron
1989
β-Thalassemia in Turkey
1990
Severe Hb S‐β°‐thalassaemia with a T → C substitution in the donor splice site of the first intron of the β‐globin gene
1989
Molecular characterization of β‐thalassaemia in 174 Greek patients with thalassaemia major
1990
Molecular characterization of β-thalassemia in Czechoslovakia
1992
The Georgia type of nondeletional hereditary persistence of fetal hemoglobin has a C---T mutation at nucleotide-114 of the A gamma-globin gene [letter]
1991
Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States
1988
Observations on the levels of Hb A2 in patients with different beta- thalassemia mutations and a delta chain variant
1990
Hematological Observations on Arabian SS Patients with a Homozygosity or Heterozygosity for a βSChromosome with Haplotype #31
1985
Mild and severe beta-thalassemia among homozygotes from Turkey: identification of the types by hybridization of amplified DNA with synthetic probes
1988
Characterization of chromosomes with hybrid genes for Hb Lepore-Washington, Hb Lepore-Baltimore, Hb P-Nilotic, and Hb Kenya
1987
A chromosome with five gamma-globin genes.
1988
Upstream promoter mutation associated with a modest elevation of fetal hemoglobin expression in human adults
1988
Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.
2007
Quantitation of hemoglobin components by high‐performance cation‐exchange liquid chromatography: Its use in diagnosis and in the assessment of cellular distribution of hemoglobin variants
1984
Haplotypes of βSChromosomes Among Patients with Sickle Cell Anemia from Georgia
1986
An A gamma type of nondeletional hereditary persistence of fetal hemoglobin with a T----C mutation at position -175 to the cap site of the A gamma globin gene
1989
A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with “silent” beta-thalassemia
1989
Pomalidomide Augments Erythropoiesis and Fetal Hemoglobin Production in a Humanized Mouse Model of Sickle Cell Disease
2008
Sickle cell anaemia among Eti‐Turks: haematological, clinical and genetic observations
1986
Abnormal arrangements in the alpha- and gamma-globin gene clusters in a relatively large group of Japanese newborns.
1986
Haplotypes and α globin gene analyses in sickle cell anaemia patients from Kenya
1987
Observations on the levels of Hb A2 in patients with different beta- thalassemia mutations and a delta chain variant
1990
Haplotypes among Vietnamese hemoglobin E homozygotes including one with a gamma-globin gene triplication.
1986
Rankless by CCL
2026